Clinical Trial Update: Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+ [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a quadruple regimen (neratinib, trastuzumab, pertuzumab, paclitaxel) in patients with advanced HER2-positive solid tumors; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)
• neratinib (neratinib)

Snippet

Sponsor: Michelle Melisko | Conditions: Solid Tumor | Phase 1 | Status: TERMINATED